Comparison of recalcitrance to ciprofloxacin and levofloxacin exhibited by Pseudomonas aeruginosa bofilms displaying rapid-transport characteristics

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 6, 1997, Pages 1352-1358

  Vrany, Julia D ^a,b,c   Stewart, Philip S ^a,b   Suci, Peter A ^a  

^a MONTANA STATE UNIVERSITY   (United States)

^b Montana State University   (United States)

^c Johnson and Johnson Company   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; LEVOFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANIMAL CELL; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ARTICLE; BIOFILM; DIFFUSION COEFFICIENT; DOSE RESPONSE; DRUG EFFICACY; DRUG TRANSPORT; FOURIER TRANSFORMATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

EID: 0030995062     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.6.1352     Document Type: Article

References (45)

1. Anwar, H., T. Biesen, M. Dasgupta, K. Lam, and J. W. Costerton. 1989. Interaction of biofilm bacteria with antibiotics in a novel chemostat system. Antimicrob. Agents Chemother. 33:1824-1826.
2. Anwar, H., and J. W. Costerton. 1990. Enhanced activity of combination of tobramycin and piperacillin for eradication of sessile biofilm cells of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 34:1666-1671.
3. Anwar, H., J. L. Strap, and J. W. Costerton. 1992. Kinetic interactions of biofilm cells of Staphylococcus aureus with cephalexin and tobramycin in a chemostat system. Antimicrob. Agents Chemother. 36:890-893.
4. Bedard, J., S. Chamberland, S. Wong, T. Schollaardt, and L. E. Bryan. 1989. Contribution of permeability and sensitivity to inhibition of DNA synthesis in determining susceptibilities of Escherichia coli, Pseudomonas aeruginosa, and Alcaligenes faecalis to ciprofloxacin. Antimicrob. Agents Chemother. 33:1457-1464.
5. Blaser, J., P. Vergères, A. F. Widmer, and W. Zimmerli. 1995. In vivo verification of in vitro model of antibiotic treatment of device-related infection. Antimicrob. Agents Chemother. 39:1134-1139.
6. Brown, M. L., H. C. Aldrich, and J. J. Gauthier. 1995. Relationship between glycocalyx and povidone-iodine resistance in Pseudomonas aeruginosa (ATCC 27853) biofilms. Appl. Environ. Microbiol. 61:187-193.
7. Chapman, J. S., and N. H. Georgopapadakou. 1988. Routes of quinolone permeation in Escherichia coli. Antimicrob. Agents Chemother. 32:438-442.
8. Chu, D. T. W., and P. B. Fernandes. 1989. Structure-activity relationships of the fluoroquinolones. Antimicrob. Agents Chemother. 33:131-135.
9. Crumplin, G. C., and J. T. Smith. 1976. Naladixic acid: an antibacterial paradox. Antimicrob. Agents Chemother. 8:251-261.
10. Dankert, J., A. H. Hogt, and J. Feijen. 1986. Biomedical polymers: bacterial adhesion, colonization, and infection. Crit. Rev. Biocompat. 2:219-301.
11. DeBeer, D., P. Stoodley, F. Roe, and Z. Lewandowski. 1993. Oxygen distribution and mass transport in biofilms. Biotechnol. Bioeng. 43:1131-1138.
12. Deretic, V., M. J. Schurr, J. C. Boucher, and D. W. Martin. 1994. Conversion of Pseudomonas aeruginosa to mucoidy in cystic fibrosis: environmental stress and regulation of bacterial virulence by alternative sigma factors. J. Bacteriol. 176:2773-2780.
13. 1 for the quinolone antibacterials. J. Med. Chem. 31:991-1001.
14. Evans, D. J., D. G. Allison, M. R. W. Brown, and P. Gilbert. 1991. Susceptibility of Pseudomonas aeruginosa and Escherichia coli biofilms towards ciprofloxacin: effect of specific growth rate. J. Antimicrob. Chemother. 27: 177-184.
15. Evans, R. C., and C. J. Holmes. 1987. Effect of vancomycin hydrochloride on Staphylococcus epidermidis biofilm associated with silicone elastomer. Antimicrob. Agents Chemother. 31:889-894.
16. Furet, Y. X., J. Deshusses, and J.-C. Pechere. 1992. Transport of pefloxacin across the bacterial cytoplasmic membrane in quinolone-susceptible Staphylococcus aureus. Antimicrob. Agents Chemother. 36:2505-2511.
17. Gilbert, P., P. J. Collier, and M. R. W. Brown. 1990. Influence of growth rate on susceptibility to antimicrobial agents: biofilms, cell cycle, dormancy, and stringent response. Antimicrob. Agents Chemother. 34:1865-1868.
18. Gootz, T. D., P. R. McGuirk, M. S. Moynihan, and S. L. Haskell. 1994. Placement of alkyl substituents on the C-7 piperazine ring of fluoroquinolones: dramatic differential effects on mammalian topoisomerase II and DNA gyrase. Antimicrob. Agents Chemother. 38:130-133.
19. Gordon, C. A., N. A. Hodges, and C. Marriott. 1988. Antibiotic interaction and diffusion through alginate and exopolysaccharide of cystic fibrosis-derived Pseudomonas aeruginosa. J. Antimicrob. Chemother. 22:667-674.
20. Gordon, C. A., N. A. Hodges, and C. Marriott. 1991. Use of slime dispersants to promote antibiotic penetration through the extracellular polysaccharide of mucoid Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 35:1258-1260.
21. Green, N. M. 1975. Avidin. Adv. Protein Chem. 29:85-133.
22. Gristina, A. G., M. Oga, L. X. Webb, and C. D. Hobgood. 1985. Adherent bacterial colonization in the pathogenesis of osteomyelitis. Science 228:990-993.
23. Hodges, N. A., and C. A. Gordon. 1991. Protection of Pseudomonas aeruginosa against ciprofloxacin and β-lactams by homologous alginate. Antimicrob. Agents Chemother. 35:2450-2452.
24. Hoyle, B. D., J. Alcantara, and J. W. Costerton. 1992. Pseudomonas aeruginosa biofilm as a diffusion barrier to piperacillin. Antimicrob. Agents Chemother. 36:2054-2056.
25. Kitamura, A., K. Hoshino, Y. Kimura, I. Hayakawa, and K. Sato. 1995. Contribution of the C-8 substituent of DU-6859a, a new potent fluoroquinolone, to its activity against DNA gyrase mutants of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 39:1467-1471.
26. Klopman, G., J.-Y. Li, S. Wang, A. J. Pearson, K. Chang, M. R. Jacobs, S. Bajaksouzian, and J. J. Ellner. 1994. In vitro anti-Mycobacterium avium activities of quinolones: predicted active structures and mechanistic considerations. Antimicrob. Agents Chemother. 38:1794-1802.
27. Korber, D. R., G. A. James, and J. W. Costerton. 1994. Evaluation of fleroxacin activity against established Pseudomonas fluorescent biofilms. Appl. Environ. Microbiol. 60:1663-1669.
28. LeChevallier, M. W., C. D. Cawthon, and R. G. Lee. 1988. Inactivation of biofilm bacteria. Appl. Environ. Microbiol. 54:2492-2499.
29. Lennette, E. H., A. Balows, W. J. Hausler, Jr., and H. J. Shadomy (ed.). 1985. Manual of clinical microbiology, 4th ed. American Society for Microbiology, Washington, D.C.
30. Marsh, P. D., and D. J. Bradshaw. 1993. Microbiological effects of new agents in dentifrices for plaque control. Int. Dent. J. 43:399-406.
31. McCaffrey, C., A. Bertasso, J. Pace, and N. H. Georgopapadakou. 1992. Quinolone accumulation in Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus. Antimicrob. Agents Chemother. 36:1601-1605.
32. Mortimer, P. G. S., and L. J. V. Piddock. 1993. The accumulation of live antibacterial agents in porin-deficient mutants of Escherichia coli. J. Antimicrob. Chemother. 32:195-213.
33. Nichols, W. W., M. J. Evans, M. P. Slack, and H. L. Walmsky. 1989. The penetration of antibiotics into aggregates of mucoid and non-mucoid Pseudomonas aeruginosa. J. Gen. Microbiol. 135:1291-1303.
34. Nichols, W. W., S. M. Dorrington, M. P. E. Slack, and H. L. Walmsley. 1988. Inhibition of tobramycin diffusion by binding to alginate. Antimicrob. Agents Chemother. 32:518-523.
35. Nickel, J. C., I. Ruseska, J. B. Wright, and J. W. Costerton. 1985. Tobramycin resistance of Pseudomonas aeruginosa cells growing as a biofilm on urinary catheter material. Antimicrob. Agents Chemother. 27:619-624.
36. Nold, S. C., and D. M. Ward. 1996. Photosynthate partitioning and fermentation in hot spring microbial mat communities. Appl. Environ. Microbiol. 62:4598-4607.
37. Pascual, A., E. Ramirez de Arellano, L. Martinez Martinez, and E. J. Perea. 1993. Effect of polyurethane catheters and bacterial biofilms on the activity of antimicrobials against Staphylococcus epidermidis. J. Hosp. Infect. 24:211-218.
38. Reichert, P. 1994. Aquasim - a tool for simulation and data analysts of aquatic systems. Water Sci. Technol. 30:21-30.
39. Stewart, P. S. 1996. Theoretical aspects of antibiotic diffusion into microbial biofilms. Antimicrob. Agents Chemother. 40:2517-2522.
40. Suci, P. A., M. W. Mittelman, F. P. Yu, and G. G. Geesey. 1994. Investigation of ciprofloxacin penetration into Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother. 38:2125-2133.
41. Sung, J. Y., J. W. Leung, E. A. Shaffer, K. Lam, and J. W. Costerton. 1993. Bacterial biofilm, brown pigment stone and blockage of biliary stents. J. Gastroenterol. Hepatol. 8:28-34.
42. Voss, E. W., Jr., W. Eshenfeldt, and R. T. Root. 1976. Fluorescein: a complete antigenic group? Immunochemistry 13:447-453.
43. Widmer, A. F., A. Wiestner, R. Frei, and W. Zimmerli. 1991. Killing of nongrowing and adherent Escherichia coli determines drug efficacy in device-related infections. Antimicrob. Agents Chemother. 35:741-746.
44. Willmott, C. J., S. E. Critchlow, I. C. Eperon, and A. Maxwell. 1994. The complex of DNA gyrase and quinolone drugs with DNA forms a barrier to transcription by RNA polymerase J. Mol. Biol. 242:351-363.
45. Wolfaardt, G. M., J. R. Lawrence, R. D. Robarts, S. J. Caldwell, and D. E. Caldwell. 1994. Multicellular organization in a degradative biofilm community. Appl. Environ. Microbiol. 60:434-446.